![Biotech Stocks Facing FDA Decision In September 2021]( "fda-aug26.jpg")
As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.
![Biotech Stocks Facing FDA Decision In August 2021]( "fda-july26.jpg")
As of this writing, the FDA has approved four novel drugs in the month of July, bringing the total number of approvals so far this year to 31.
![Ten Most Valuable Companies In The US]( "slideshow-preview-062521.jpg")
The ten most valuable companies in the U.S., based on market capitalization, are worth over $11 trillion in total.
![Biotech Stocks Facing FDA Decision In July 2021]( "fda-jun22.jpg")
In June, as of this writing, two novel drugs have secured the FDA nod – Brexafemme and Aduhelm.